Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
John R. Srigley, Brett Delahunt, John N. Eble, et al.
The American Journal of Surgical Pathology (2013) Vol. 37, Iss. 10, pp. 1469-1489
Open Access | Times Cited: 1012

Showing 1-25 of 1012 citing articles:

EAU Guidelines on Renal Cell Carcinoma: 2014 Update
Börje Ljungberg, Karim Bensalah, Steven Canfield, et al.
European Urology (2015) Vol. 67, Iss. 5, pp. 913-924
Open Access | Times Cited: 3325
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
Holger Moch, Antonio L. Cubilla, Peter A. Humphrey, et al.
European Urology (2016) Vol. 70, Iss. 1, pp. 93-105
Closed Access | Times Cited: 2722
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Bernard Escudier, Camillo Porta, Manuela Schmidinger, et al.
Annals of Oncology (2014) Vol. 25, pp. iii49-iii56
Open Access | Times Cited: 2123
Renal cell carcinoma
James J. Hsieh, Mark P. Purdue, Sabina Signoretti, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 2089
Renal Mass and Localized Renal Cancer: AUA Guideline
Steven C. Campbell, Robert G. Uzzo, Mohamad E. Allaf, et al.
The Journal of Urology (2017) Vol. 198, Iss. 3, pp. 520-529
Open Access | Times Cited: 1143
Systemic Therapy for Metastatic Renal-Cell Carcinoma
Toni K. Choueiri, Robert J. Motzer
New England Journal of Medicine (2017) Vol. 376, Iss. 4, pp. 354-366
Closed Access | Times Cited: 1107
Renal cancer
Umberto Capitanio, Francesco Montorsi
The Lancet (2015) Vol. 387, Iss. 10021, pp. 894-906
Closed Access | Times Cited: 870
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
Brett Delahunt, John C. Cheville, Guido Martignoni, et al.
The American Journal of Surgical Pathology (2013) Vol. 37, Iss. 10, pp. 1490-1504
Closed Access | Times Cited: 756
Treatment of renal cell carcinoma: Current status and future directions
Pedro Barata, Brian I. Rini
CA A Cancer Journal for Clinicians (2017) Vol. 67, Iss. 6, pp. 507-524
Open Access | Times Cited: 750
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
Samra Turajlic, Hang Xu, Kevin Litchfield, et al.
Cell (2018) Vol. 173, Iss. 3, pp. 595-610.e11
Open Access | Times Cited: 563
Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity
Brian Shuch, Ali Amin, Andrew J. Armstrong, et al.
European Urology (2014) Vol. 67, Iss. 1, pp. 85-97
Closed Access | Times Cited: 492
Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
Steffen Durinck, Eric Stawiski, Andrea Pavía-Jiménez, et al.
Nature Genetics (2014) Vol. 47, Iss. 1, pp. 13-21
Open Access | Times Cited: 334
Best Practices Recommendations in the Application of Immunohistochemistry in Urologic Pathology
Mahul B. Amin, Jonathan I. Epstein, Thomas M. Ulbright, et al.
The American Journal of Surgical Pathology (2014) Vol. 38, Iss. 8, pp. 1017-1022
Closed Access | Times Cited: 312
Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment
Fred H. Menko, Eamonn R. Maher, Laura S. Schmidt, et al.
Familial Cancer (2014) Vol. 13, Iss. 4, pp. 637-644
Open Access | Times Cited: 301
Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma
Anthony J. Gill, Ondřej Hes, Thomas Papathomas, et al.
The American Journal of Surgical Pathology (2014) Vol. 38, Iss. 12, pp. 1588-1602
Open Access | Times Cited: 300
Immune infiltration in renal cell carcinoma
Shichao Zhang, Erdong Zhang, Jinhua Long, et al.
Cancer Science (2019) Vol. 110, Iss. 5, pp. 1564-1572
Open Access | Times Cited: 276
Tuberous Sclerosis–associated Renal Cell Carcinoma
Juan Guo, Maria Tretiakova, Megan L. Troxell, et al.
The American Journal of Surgical Pathology (2014) Vol. 38, Iss. 11, pp. 1457-1467
Closed Access | Times Cited: 255
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal Cancer
Ying‐Bei Chen, A. Rose Brannon, Antoun Toubaji, et al.
The American Journal of Surgical Pathology (2014) Vol. 38, Iss. 5, pp. 627-637
Open Access | Times Cited: 248
MiT family translocation renal cell carcinoma
Pedram Argani
Seminars in Diagnostic Pathology (2015) Vol. 32, Iss. 2, pp. 103-113
Closed Access | Times Cited: 247
Choosing the right cell line for renal cell cancer research
Klaudia Brodaczewska, Cezary Szczylik, Michał Fiedorowicz, et al.
Molecular Cancer (2016) Vol. 15, Iss. 1
Open Access | Times Cited: 238
Renal Cell Carcinoma in Tuberous Sclerosis Complex
Ping Yang, Kristine M. Cornejo, Peter M. Sadow, et al.
The American Journal of Surgical Pathology (2014) Vol. 38, Iss. 7, pp. 895-909
Open Access | Times Cited: 234
Fumarate Hydratase–deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome
Kiril Trpkov, Ondřej Hes, Abbas Agaimy, et al.
The American Journal of Surgical Pathology (2016) Vol. 40, Iss. 7, pp. 865-875
Open Access | Times Cited: 216
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial
Sumanta K. Pal, Catherine M. Tangen, Ian M. Thompson, et al.
The Lancet (2021) Vol. 397, Iss. 10275, pp. 695-703
Open Access | Times Cited: 213
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
Sean R. Williamson, John N. Eble, Mohammed A. Amin, et al.
Modern Pathology (2014) Vol. 28, Iss. 1, pp. 80-94
Open Access | Times Cited: 209
Landmarks in the diagnosis and treatment of renal cell carcinoma
Jaimin R. Bhatt, Antonio Finelli
Nature Reviews Urology (2014) Vol. 11, Iss. 9, pp. 517-525
Closed Access | Times Cited: 198
Page 1 - Next Page

Scroll to top